DR. ELENI KONSTANTINOU MD
Prescription History 1548798317
Ophthalmology - Retina Specialist in New York, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ELENI KONSTANTINOU MD, an active Retina Specialist specialist practicing in New York, NY. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 16 documented patient claims. Among these therapy options, the most frequently utilized medication is Methotrexate Sodium, which accounts for 16 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Claims | 30-Day Fills | Days Supply | Cost / Claim | Utilization vs NY Avg |
|---|---|---|---|---|---|
| Methotrexate SodiumMethotrexate Sodium/Pf | 16 | 16.0 | 17 | $3.43▼ below NY avg | ▼ Below Avg. |
Utilization: claims vs the average NY prescriber Averages are among NY prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the NY average This provider's average cost per claim is below the NY average for this medication. 16.0 30-Day Fills 17 Days Supply About Methotrexate Sodium: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma) or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. Show more ▾ It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. | |||||
About this data. The prescription history for DR. ELENI KONSTANTINOU MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Retina Specialist prescribing approach at this New York, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
